22nd Century Launches VLN® Cigarettes at Circle K
22nd Century Group, Inc. (Nasdaq: XXII) is excited to announce the launch of its VLN® reduced nicotine content cigarettes at around 140 Circle K convenience store locations in Illinois. This significant rollout marks a substantial step for the company as it continues to champion smoking harm reduction through innovative products, now authorized for sale in 45 states across the U.S.
Expanding Availability and Marketing Initiatives
Larry Firestone, the Chief Executive Officer of 22nd Century Group, expressed enthusiasm for re-establishing a presence in Illinois, noting that it was the first market the company targeted back in 2022. As part of their strategy, new marketing and consumer education materials have been introduced, featuring the complete range of VLN® cigarette products. These efforts aim to provide clarity for customers seeking answers about where to buy VLN® and enhance brand recognition within local communities.
State Authorizations and Future Goals
The company is working diligently to obtain authorizations in all 50 states, with only five states left to secure. Once achieved, 22nd Century plans to illustrate the viability of its VLN® and partner VLN® low nicotine products. This initiative aligns with recent mandates from the FDA, emphasizing the importance of reduced nicotine content in combating addiction.
The Science Behind VLN® Cigarettes
The VLN® and Partner VLN® cigarettes feature a proprietary blend of tobacco engineered to have 95% less nicotine than traditional cigarettes. Clinical studies have suggested that such reductions can lead to a decrease in overall smoking rates among users. These products stand out as the first combusted tobacco items compliant with upcoming FDA regulations, showcasing 22nd Century's commitment to innovation in the tobacco industry.
Innovative Tobacco Solutions
22nd Century's unique non-GMO tobacco plants come from advanced technologies designed to control alkaloid biosynthesis. This results in a product that not only meets safety standards but also caters to the growing demand for health-conscious alternatives in the tobacco market. The intellectual property portfolio of 22nd Century is extensive, ensuring that its nicotine-reduced tobacco can be produced effectively at scale.
Commitment to Health and Harm Reduction
VLN® is not just a product but represents a movement in tobacco harm reduction. The product is created with the goal of allowing smokers to take control of their nicotine intake, providing a satisfying smoking experience without the excessive nicotine content of traditional cigarettes. 22nd Century's commitment is reflected in its efforts to support the FDA's public health objectives and promote safer smoking options.
FDA Authorization Recognition
Importantly, the VLN® cigarette stands as the only low nicotine combustible cigarette officially authorized by the FDA in the United States, setting a high standard in the industry and paving the way for future tobacco products.
Investor Relations and Company Contact
For more information, interested parties can reach out to:
Matt Kreps
Investor Relations
22nd Century Group
investorrelations@xxiicentury.com
214-597-8200
Frequently Asked Questions
What are VLN® cigarettes?
VLN® cigarettes are reduced nicotine content cigarettes developed by 22nd Century Group to help smokers manage their nicotine intake.
Where are VLN® cigarettes available?
As of now, VLN® cigarettes are authorized for sale in 45 states and are available at Circle K stores in Illinois.
What is the nicotine content of VLN® cigarettes?
VLN® cigarettes contain 95% less nicotine compared to traditional tobacco cigarettes.
Is 22nd Century Group publicly traded?
Yes, 22nd Century Group, Inc. is publicly traded under the ticker symbol Nasdaq: XXII.
How does 22nd Century Group support health initiatives?
The company focuses on tobacco harm reduction by creating products that adhere to FDA mandates for reduced nicotine levels, promoting safer alternatives in smoking.
